| [gamma]-[delta] T lymphocytes in mice and man: A review | p. 1 |
| Ontogeny, features and functions of epidermal T lymphocytes | p. 17 |
| Activation of reactive versus malignant T-cells in cutaneous T-cell lymphoma: Role of abnormal antigen presenting cells and T-cell activating molecules | p. 29 |
| Factors involved in the localization and activation of murine [gamma]-[delta] positive dendritic epidermal T cells | p. 39 |
| Morpho-antigenic features of dendritic cells as a clue to the interpretation of skin immune system-related disorders | p. 57 |
| Cell trafficking networks in cutaneous T-cell lymphoma | p. 77 |
| Cytokine neuropeptide interactions in the skin | p. 95 |
| Effect of UV light on cytokine production by epidermal cells | p. 103 |
| Adhesion molecules involved in the extravasation of lymphocytes in lymphoid organs and chronically inflamed tissues | p. 113 |
| Adhesion receptors in normal skin and cutaneous malignant lymphomas: Pathophysiological and clinical correlations | p. 141 |
| Integrins and homing receptors in cutaneous lymphomas | p. 157 |
| A new retrovirus from cutaneous T-cell lymphoma | p. 177 |
| Survey of cutaneous T-cell lymphomas for human T-lymphotropic virus infection | p. 185 |
| HTLV-I proviral sequences in cutaneous CD30[superscript +] T-large cell lymphomas | p. 195 |
| Presence of Epstein-Barr viral DNA and EBV latent gene products in Hodgkin and non-Hodgkin lymphoma: High expression of EBV-DNA sequences in non-Hodgkin lymphoma with variable numbers of CD30 positive cells | p. 205 |
| Inflammatory precursors of mycosis fungoides | p. 217 |
| The histological spectrum of cutaneous T-cell lymphoma | p. 231 |
| Cutaneous T-cell lymphoma: Clues to diagnosis in early lesions | p. 243 |
| Morphologic and prognostic features of advanced mycosis fungoides | p. 255 |
| Primary cutaneous CD30 (Ki-1) positive large cell lymphomas: Definition and differential diagnostic aspects | p. 265 |
| Analysis of clinical, histopathologic and immunopathologic parameters in erythrodermic variants of cutaneous T-cell lymphoma with implications for staging | p. 275 |
| A scoring system based on differentially weighted criteria for establishing a standardized threshold for the diagnosis of early mycosis fungoides | p. 291 |
| Cutaneous B-cell lymphoma: A SALT-related tumor? | p. 301 |
| Proliferation activity in skin lesion of mycosis fungoides: Prognostic and pathophysiologic implications | p. 317 |
| Erythrodermic actinic reticuloid | p. 325 |
| Morphometric study of primary cutaneous germinal center cell lymphomas | p. 333 |
| BCL-2 gene rearrangement and protein expression in primary cutaneous B-cell lymphomas | p. 343 |
| Changing concepts on cutaneous pseudo-B-cell lymphomas and their relationship to cutaneous B-cell lymphomas | p. 355 |
| Diagnostic and prognostic significance of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with cutaneous T-cell lymphoma | p. 363 |
| Analysis of T-cell receptor gene configurations in mycosis fungoides | p. 369 |
| The pathogenesis of lymphomatoid papulosis | p. 379 |
| T-cell receptor variable region gene expression in cutaneous T-cell lymphoma | p. 393 |
| Sezary syndrome is characterized by genotraumatic T-cells | p. 401 |
| Chromosome abnormalities in cutaneous B-cell lymphomas | p. 419 |
| Mechanism for tumor progression in lymphomatoid papulosis: Hypothesis based on studies of tumor cell lines clonally derived from lymphomatoid papulosis | p. 425 |
| Shedding of interleukin-2 receptor in cutaneous lymphomas: An effective mechanism to circumvent immunosurveillance? | p. 435 |
| The skin as a target organ during IL-2 administration | p. 451 |
| Specific immune response against melanoma: Analysis at a clonal level | p. 459 |
| Response of early stage cutaneous T-cell lymphoma to ultraviolet B phototherapy | p. 469 |
| A murine T-cell lymphoma model showing protection against tumor development and treatment of established disease | p. 483 |
| Molecular mechanisms responsible for repair of adducts induced in human cellular DNA by PUVA | p. 497 |
| Interferon modulates lymphoproliferation in the skin | p. 535 |
| Use of recombinant interferon-[alpha]-2a in the treatment of cutaneous lymphomas of T- and B-cell lineage | p. 545 |
| Thymopentin in Sezary syndrome: Clinical and immunological effects | p. 553 |
| What is mycosis fungoides? A modest proposal | p. 565 |
| Terms and abbreviations used used in cutaneous lymphoproliferative phenomena | p. 579 |
| Conference picture | p. 613 |
| Index of authors and conference participants | p. 615 |
| Index | p. 617 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
